Québec, Canada

Thierry Groblewski

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 3(Granted Patents)

Forward Citations (Not Self Cited) = 2(Sep 21, 2024)

Location History:

  • St Laurent, CA (2007)
  • Québec, CA (2011 - 2015)


Years Active: 2007-2015

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):
1 patent (CIPO):

Title: **Inventor Thierry Groblewski: Pioneering Advancements in Cyclopropyl Amide Derivatives**

Introduction

Thierry Groblewski is an accomplished inventor based in Québec, Canada. He has contributed significantly to the field of pharmaceutical chemistry, particularly with his innovative work on cyclopropyl amide derivatives. With a total of three patents to his name, Groblewskis inventions hold promise for treating various medical conditions.

Latest Patents

Thierry Groblewski's latest patents include groundbreaking advancements related to cyclopropyl amide derivatives. These patents disclose at least one cyclopropyl amide derivative that can be utilized in pharmaceutical compositions. Moreover, the methods outlined in these patents aim at using these derivatives for treating conditions associated with histamine H3 receptors. His work in this area is crucial as it offers new avenues for therapeutic interventions.

Career Highlights

Currently, Thierry Groblewski is associated with AstraZeneca, a leading global biopharmaceutical company. His role involves extensive research and development, focusing on innovative drug formulations and their potential applications. Groblewskis contributions to the pharmaceutical domain span several years, reflecting his dedication to improving healthcare through innovative solutions.

Collaborations

Throughout his career, Thierry Groblewski has collaborated with esteemed colleagues such as James Arnold and Todd Andrew Brugel. These partnerships have fostered an environment of creativity and knowledge exchange, further enhancing the innovative culture within AstraZeneca.

Conclusion

In summary, Thierry Groblewski is a notable inventor whose work on cyclopropyl amide derivatives paves the way for potential breakthroughs in treating health conditions linked to histamine H3 receptors. His ongoing contributions at AstraZeneca, along with collaborative efforts with other professionals, highlight the importance of innovation in the pharmaceutical industry. With three patents to his name, Groblewski continues to make a significant impact in the field of drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…